Floatz logo

ca-4948

Refractory Primary Central Nervous System Lymphoma

Curis, Inc.Small moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Refractory Primary Central Nervous System Lymphoma cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

ca-4948 is also rated in:

acute myeloid leukemiaDormant
B
Indicative ·
58 / 100
View asset →
myelodysplastic syndromeDormant
CCC
Indicative ·
55 / 100
View asset →
B-cell neoplasmDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →